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Abstract Oenothera paradoxa (EP) preparations are com-
monly used in folk medicine to treat skin diseases, neuralgia,
and gastrointestinal (GI) disorders. Several reports suggested
that EP preparations exhibit potent anti-inflammatory and
antioxidant activities both in vitro and in vivo. Here, we aimed
to characterize the action of EP pomace polyphenol extract in
mouse model of colitis. We analyzed the composition of EP
pomace polyphenol extract using reversed phase HPLC sys-
tem and ultra-performance liquid chromatography (UPLC)
system coupled with a quadrupole-time of flight (Q-TOF)
MS instrument. Then, we used a well-established animal
model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced
colitis to determine the anti-inflammatory action of EP pom-
ace polyphenol extract. We also investigated the effect of the
EP pomace polyphenol extract on pro-inflammatory (IL-1β
and TNF-α) cytokine mRNA levels and hydrogen peroxide
concentration in the inflamed colon. Administration of EP
pomace polyphenol extract significantly improved macro-
scopic and microscopic damage scores, as well as
myeloperoxidase (MPO) activity in TNBS-treated mice. The
anti-inflammatory effect of the extract was observed after
intracolonic and oral administration and was dose-dependent.
Significant reduction of tissue hydrogen peroxide level after
treatment with EP pomace polyphenol extract suggests that its
therapeutic effect is a result of free radical scavenging. This
novel finding indicates that the application of the EP pomace
polyphenol extract in patients with inflammatory bowel dis-
eases (IBDs) may become an attractive supplementary treat-
ment for conventional anti-inflammatory therapy.
Keywords Evening primrose . Experimental colitis .
Inflammatory bowel diseases
Introduction
Evening primrose (Oenothera paradoxa) is a biennial herb
originating from Mexico and Central America. Throughout
the years, it has become a widespread plant occurring in both
Americas, Europe, and parts of Asia (Bayles and Usatine
2009). The Native Americans valued evening primrose stem
and leaf juices as topical remedies to alleviate cutaneous
inflammation (Bayles and Usatine 2009). An extract made
of O. paradoxa (EP) roots was applied to treat obesity and
abdominal pain (Singh et al. 2012). EP has also been used in
folk medicine as a remedy for neuralgia, skin, liver, kidney,
and gastrointestinal (GI) diseases (Singh et al. 2012).
Several secondary metabolites, which are present in vari-
ous parts of the plant, contribute to the therapeutic actions of
EP. For instance, anti-inflammatory and radical scavenging
triterpenoids and low molecular weight phenolic antioxidants
occur in EP seeds, while flavonoids with anticancer activity
can be found in the whole plant (Knorr and Hamburger 2004;
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Montserrat-de la Paz et al. 2012; Singh et al. 2012;
Wettasinghe et al. 2002). Clinical evidence for therapeutically
relevant action of EP has recently been reported. The EP oil is
best known for its beneficial effect on the chronic inflamma-
tory disorders, such as atopic dermatitis and rheumatoid ar-
thritis (Bayles and Usatine 2009). It is also used as an analge-
sic agent in breast pain (mastalgia) (Bayles and Usatine 2009).
Moreover, the potential application of EP oil in diabetes
mellitus, asthma, and schizophrenia is currently being inves-
tigated (Bayles and Usatine 2009). Several reports suggest
that use of various EP preparations exhibits therapeutic prop-
erties in the GI tract (al-Shabanah 1997; Gorlach et al. 2011;
Greenfield et al. 1993).
Inflammatory bowel diseases (IBDs) are a group of chronic
inflammatory GI disorders, consisting of Crohn’s disease
(CD) and ulcerative colitis (UC) that may cause a substantial
worsening of life quality (Ng et al. 2013). Currently available
pharmacotherapeutic treatment strategies for IBD comprise
corticosteroids, immunosuppressants, and antibodies against
tumor necrosis factor (TNF-α) (Ng et al. 2013).
In the recent years, the use of complementary and alterna-
tive medicine (CAM) has been perceived as attractive by
patients with IBD and is systematically becoming more and
more popular. Population-based and cohort studies have
shown that prevalence of current or past CAM use in adult
IBD populations fromNorth America and Europe ranges from
21 up to 60 % (Ng et al. 2013).
The aim of the present study was to extend previously
reported findings on the therapeutic significance of EP prep-
arations by characterizing the anti-inflammatory potential of
polyphenol extract from EP pomace, which is a residue that
remains after oil extrusion from the seeds.
Materials and methods
Chemicals
Acetonitrile, elagic acid, (+)-catechin, formic acid, gallic acid,
methanol, methyl gallate, protocatechuic acid, and vanillinwere
purchased from Sigma-Aldrich Chemicals Co. (Poznan,
Poland) and quercetin glucoside from Extrasynthese (Lyon,
France). All other chemicals were reagent-grade products pur-
chased from POCH (Gliwice, Poland).
Plant materials
Evening primrose (O. paradoxa) pomace defatted seeds were
obtained from Agropharm S.A. (Tuszyn, Poland). Pomace
contains waste material from the cold pressing of evening
primrose oil. Such material is almost completely deprived
from lipids and fatty acids. Moreover, remaining lipids and
fatty acids were removed from the material during extraction,
which is described in detail below.
Preparation of the polyphenol extract
Evening primrose pomace (90 g) obtained in the process of oil
pressing was milled and defatted with hexane. The first ex-
traction lasted 30 min and was followed by two 15-min
extractions. The ratio of the plant material to hexane was 1:5
(w/v) in the first extraction and 1:2.5 (w/v) in the second and
third. The hexane extracts were centrifuged (15 min,
4,000 rpm), and defatted seeds were dried at room temperature
for 24 h. Polyphenols were extracted from the defatted seeds
(81.6 g) with the use of a 70 % aqueous solution of ethanol at
room temperature. The ratio of plant material to ethanol solu-
tion was 1:10 (w/v) in the first extraction and 1:5 (w/v) in the
next two extractions. The ethanol extracts were centrifuged
(15 min, 4,000 rpm), combined, and evaporated under vacu-
um at ≤40 °C (Rotavapor RII, BUCHI, Flawil, Switzerland).
The obtained aqueous solution of the evening primrose poly-
phenols was lyophilized (Alpha 1-2 LD plus, Christ,
Osterode, Germany). The final dry extract (9.91 g) was stored
at 4 °C prior to further analyses.
Total phenolic content
The total phenolic content of the polyphenol extract was
determined using Folin-Ciocalteu reagent, based on the meth-
od described by Bordonaba and Terry (2008) with some
modification. Accurately weighed 20 mg of extracts was
dissolved in 10 mL of 10 % aqueous dimethyl sulfoxide
(DMSO); then, 0.1–0.2 mL were mixed with 25 mL of water,
0.5 mL of Folin-Ciocalteu reagent, and 5 mL of 20 % sodium
carbonate and made up to 50 mL with distilled water. The
mixture was kept for 20 min at room temperature, after which
the absorbance was read at 760 nm. (+)-Catechin was used as
a reference standard, and the results were expresses as (+)-
catechin equivalents/g of dry extract.
Total flavan-3-ol content
The vanillin assay was performed as described by Swain and
Hillis (1959), with some modification. Briefly, a volume of
2 mL of a known dilution of the preparation solution in water
was placed in two test tubes, and 4 mL of 1 % (w/v) vanillin in
70 % sulfuric acid (A) or 4 mL of 70 % sulfuric acid (B) was
added to a sample. Additionally, a blank was prepared by
mixing 2 mL of water with vanillin solution (C). All test tubes
were shaken in a bath of cold water to prevent the temperature
from rising above 35 °C. After incubation in cold water for
15 min, the absorbance of samples A, B, and C was read at
500 nm against a mixture of 2 mL of water and 4 mL of 70 %
sulfuric acid. The final absorbance is equal to the difference
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(A−B−C). Flavanol content was calculated from a calibration
curve, using (+)-catechin as standard. Results were expressed
as milligram catechin equivalents/g of dry extract.
Hydrolyzable tannin content
Hydrolyzable tannin content in the obtained extract was esti-
mated by an HPLC method after acid hydrolysis of tannins
into methyl gallate according to Hartzfeld et al. (2002) with
some modifications. Briefly, 5–10-mg samples of dry poly-
phenol extract were weighed into 25-mL Pyrex screw top
tubes with Teflon cap liners, and 4mL ofmethanol was added,
followed by 0.4mL of concentrated sulfuric acid. The samples
were placed in a heating block previously preheated to 85 °C
and were allowed to react for 20 h. After cooling, 0.4 mL of
ethanolamine (commercial preparation, 100 % ethanolamine)
was added to the mixture, and the volume was adjusted to
10 mL with distilled water. Prior to HPLC analysis, the
samples were centrifuged for 3 min (13,000 rpm) and filtered
through a 0.45-μm syringe filter Minisart RC4 (Sartorius,
Goettingen, Germany). Methyl gallate was determined using
analytical reversed phase HPLC system (Waters, Milford,
MA, USA) with autosampler 2707 and binary HPLC pump
1525 coupled to a 996 photodiode array detector (2998),
controlled by Waters Breeze 2 software. Separation was per-
formed on a SYMMETRY C18 (250 mm×4.6 mm, 5 μm)
column (Waters, Milford, MA, USA). The binary mobile
phase according to Dyrby et al. (2001) consisted of water
and formic acid in the ratio of 90:10 (v/v), respectively (sol-
vent A), water, acetonitrile, and formic acid in the ratio of
49:50:1 (v/v/v), respectively (solvent B). The separation of
phenolic was performed using the following gradient program
with a flow rate of 1 mL/min: 0 min, 88%A+12%B; 26min,
70 % A+30 % B; 40–43 min, 0 % A+100 % B; and 48–
50 min, 88 % A+12 % B. Detection was performed by
scanning from 200 to 550 nm. The methyl gallate (detection
at 280 nm) was analyzed and quantified as methyl gallate
equivalents/g of dry extract.
UPLC-Q-TOF-MS conditions
Identification of polyphenol compounds was performed on an
Acquity ultra-performance liquid chromatography (UPLC)
system coupled with a quadrupole-time of flight (Q-TOF)
MS instrument (UPLC/Synapt Q-TOF MS, Waters, Milford,
MA, USA) with an electrospray ionization (ESI) source ac-
cording to Wojnicz et al. (2012). Separation was achieved on
an AcquityTM BEH C18 column (100 mm×2.1 mm i.d.,
1.7 μm;Waters). Mobile phase was a mixture of 4.5 % formic
acid (A) and acetonitrile (B). The gradient program was as
follows: initial conditions 99 % (A); 12 min, 75 % (A);
12.5 min, 100 % (B); 13.5 min, 99 % (A). The flow rate
was 0.45 mL/min. The major operating parameters for the Q-
TOF MS were set as follows: capillary voltage, 2.0 kV; cone
voltage, 45 V; cone gas flow, 11 L/h; collision energy, 50 eV;
source temperature, 100 °C; desolvation temperature, 250 °C;
collision gas, argon; desolvation gas, nitrogen; flow rate,
600 L/h; data acquisition range,m/z 100–1,000 Da; ionization
mode, negative.
HPLC analysis of phenolic compounds
HPLC analysis was performed using analytical reversed phase
HPLC system (Dionex, Sunnyvale, CA, USA) with
autosampler EWPS-3000SI and pump LPG-3400A coupled
to a photodiode array detector (Ultimate 3000), controlled by
Chromeleon v. 6.8 software, according to Kucharska (2012).
Separation was performed on an Atlantis T3 (250 mm×
4.6 mm i.d., 5 μm; Waters, Dublin, Ireland). The eluent was
4.5 % formic acid (A) and acetonitrile (B). A gradient solvent
system was used: 0–1 min, 5 % (B); 1–6 min, 10 % (B); 6–
26 min, 20 % (B); and 26–33 min, 100 % (B). The flow rate
was 1 mL/min, and the injection volume was 20 μL. Detector
was set at 254 nm for elagic acid and protocatechuic acid;
280 nm for gallic acid, flavan-3-ol derivatives, and hydrolyz-
able tannin derivatives; and 360 nm for flavonol derivatives.
The amounts of flavan-3-ol derivatives were expressed as (+)-
catechin equivalents, hydrolyzable tannin derivatives as gallic
acid equivalents, and flavonols as quercetin equivalents/g of
dry extract.
Animals
Experimentally naive male C57B1/6 mice were obtained from
the Animal House of the University of Lodz, Poland. All
animals used in experiments weighed 22–30 g. The animals
were housed at a constant temperature (22 °C) and maintained
under a 12-h light/dark cycle (lights on at 6:00 a.m.) in
sawdust-lined plastic cages with access to chow pellets and
tap water ad libitum. All animal protocols were in accordance
with the European Communities Council Directive of 24
November 1986 (86/609/EEC) and Polish legislation acts
concerning animal experimentation. The experimental proto-
col was approved by the Local Ethics Committee at the
Medical University of Lodz (#670/2013). All efforts were
made to minimize animal suffering and to reduce the number
of animals used.
Induction of colitis and evaluation of disease progress
parameters
Experimental colitis was induced by intracolonic (i.c.) admin-
istration of 2,4,6-trinitrobenzenesulfonic acid (TNBS, 4 mg in
0.1 mL of 30 % ethanol in saline), as described earlier by
Fichna et al. (2012). Three days after TNBS infusion, animals
were sacrificed by cervical dislocation. Then, the colon was
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isolated, opened longitudinally, rinsed with phosphate-
buffered saline (PBS), and immediately examined.
Macroscopic colon damage was assessed by an established
semiquantitative scoring system by adding individual scores
for ulcer, colon shortening, wall thickness, and presence of
hemorrhage, fecal blood, and diarrhea, as described before
(Fichna et al. 2012). For scoring ulcer, colon shortening, and
colon wall thickness, the following scale was used: ulcer, 0.5
points for each 0.5 cm; shortening of the colon, 1 point for
>15 %, 2 points for >25 % (based on a mean length of the
colon in untreated mice of 7.97±0.21 cm, n=6); the wall
thickness was measured in mm, a thickness of n mm corre-
sponds to n scoring points. The presence of hemorrhage, fecal
blood, or diarrhea increased the score by 1 point for each
additional feature. Body weight of animals was recorded once
daily during whole experiment. All colon samples for further
experiments were collected during macroscopic evaluation
process.
Determination of myeloperoxidase activity
Myeloperoxidase (MPO) activity was assessed in the mouse
colon specimens according to the method described earlier by
Fichna et al. (2012). Briefly, 1-cm segments of the colon were
weighed and homogenized in hexadecyltrimethylammonium
bromide (HTAB) buffer (0.5 % HTAB in 50-mM potassium
phosphate buffer, pH 6.0; 1:20w/v) immediately after isolation.
The homogenate was centrifuged (15min, 13,200g, 4 °C). On a
96-well plate, 200 μL of 50-mM potassium phosphate buffer
(pH 6.0), containing 0.167 mg/mL ofO-dianisidine hydrochlo-
ride and 0.05 μL of 1 % hydrogen peroxide, was added to 7 μL
of supernatant. Absorbance was measured at 450 nm (iMARK
Microplate Reader, Biorad, Hertfordshire, UK). All measure-
ments were performed in triplicate. MPO was expressed in
milliunits per gram of wet tissue, 1 unit being the quantity of
enzyme able to convert 1 μmol of hydrogen peroxide to water
in 1 min at room temperature. Units of MPO activity per 1 min
were calculated from a standard curve using purified peroxidase
enzyme.
Histology
After the macroscopic scoring, segments of the distal colon
were stapled flat, mucosal side up, onto cardboard and fixed in
10% neutral-buffered formalin for 24 h at 4 °C. Samples were
then dehydrated, embedded in paraffin, sectioned at 5 μm,
and mounted onto slides. Subsequently, sections were
stained with hematoxylin and eosin and examined using
Motic AE31 microscope (Ted Pella, Vendelsö, Sweden).
Photographs were taken using a digital imaging system
consisting of a digital camera (Moticam 2300, Ted
Pella, Vendelsö, Sweden) and image analysis software
(Motic Images Plus 2.0, Wetzlar, Germany).
A microscopic total damage score was determined based
on the presence (score=1) or absence (score=0) of goblet cell
depletion, the presence (score=1) or absence (score=0) of
crypt abscesses, the destruction of mucosal architecture (nor-
mal=1, moderate=2, extensive=3), the extent of muscle
thickening (normal=1, moderate=2, extensive=3), and the
presence and degree of cellular infiltration (normal=1, mod-
erate=2, transmural=3).
Determination of IL-1β and TNF-α mRNA levels
RNAwas isolated according to manufacturer’s protocol using
PureLink RNA Mini kit (Life Technologies, Carlsbad, CA,
USA). Briefly, tissue samples were homogenized in lysis
buffer (600 μL), complemented with 1 % 2-mercaptoethanol
(St. Louis, MO, USA). Subsequently, the homogenates were
centrifuged to clear the solution. Supernatants were placed
onto ion exchange columns, and finally, purified total RNA
was eluted using diethyl pyrocarbonate (DEPC)-treated water
(50 μL). To measure the purity and quantity of isolated RNA,
dedicated spectrophotometer (BioPhotometer; Eppendorf,
Germany) was used. Total RNA (1 μg) was transcribed onto
cDNA with First-Strand cDNA synthesis kit (Fermentas,
Burlington, Canada). Quantitative analysis was performed
u s i n g f l u o r e s c e n t l y l a b e l e d Ta qMa n p r o b e
Mm00434228_m1 for mouse IL-1β, Mm00443260_g1 for
mouse TNF-α , and Mm01545399_m1 for mouse
hypoxanthine-guanine phosphoribosyltransferase (HPRT) as
endogenous control (Life Technologies, Carlsbad, CA, USA)
onMastercycler S realplex 4 apparatus (Eppendorf, Hamburg,
Germany) and TaqMan Gene Expression Master Mix (Life
Technologies, Carlsbad, CA, USA) in accordance with man-
ufacturer’s protocol. All experiments were performed in
triplicate.
The Ct (threshold cycle) values for studied genes were
normalized to Ct values obtained for a housekeeping gene
HPRT. Relative amount of mRNA copies was calculated
using the following equation: 2−ΔCt×1,000.
Determination of H2O2
Briefly, 50 mg of colon tissue fragment was homogenized
with 2 mL of 1.15 % potassium chloride. Then, 10-μL aliquot
of tissue homogenate was mixed with 90 μL of PBS (pH 7.0)
and 100 μL of horseradish peroxidase (1 U/mL) containing
400μmol homovanilic acid (HRP+HVA assay) or with 90μL
of PBS and 100 μL of 1 U/mL horseradish peroxidase only
(HRP assay). Both homogenates were incubated for 60 min at
37 °C. Subsequently, 300 μL of PBS and 125 μL of 0.1 M
glycine-NaOH buffer (pH 12.0) with 25 mM EDTA were
added to each homogenate sample. Excitation was set at
312 nm, and emission was measured at 420 nm (Perkin
Elmer Luminescence Spectrometer, Beaconsfield UK).
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Readings were converted into H2O2 concentration using the
regression equation: Y=0.012X–0.007, where Y=H2O2 con-
centration in homogenate (μM); X=intensity of light emission
at 420 nm for HRP+HVA assay reduced by HRP assay
emission (arbitrary units, AU). The regression equation was
prepared from three series of calibration experiments with ten
increasing H2O2 concentrations (range 10–1,000 μM). The
lowest H2O2 detection was 0.1 nM, with intra-assay variabil-
ity not exceeding 2 %.
Pharmacological treatments
The EP pomace polyphenol extract was administered twice
daily at the dose of 1, 5, and 10 mg/kg (orally, p.o., or i.c.) in
TNBS model, with the first treatment 30 min before the
induction of colitis. 5-Aminosalicylic acid (5-ASA), which
was used as a positive control for the effect of the EP pomace
polyphenol extract in TNBS-induced colitis, was administered
at the dose of 5 mg/kg (i.c.) 10 min before TNBS infusion.
Saline was used as vehicle and did not influence the observed
parameters when given alone. Control animals received vehi-
cle alone (100 μL i.c. or 150 μL p.o.).
Statistics
Statistical analysis was performed using Prism 5.0 (GraphPad
Software Inc., La Jolla, CA, USA). The data are expressed as
means±SEM. Student’s t test or one-way ANOVA followed
by Newman-Keuls post hoc test were used for analysis. P
values <0.05 were considered statistically significant.
Results
Chemical characteristic of EP pomace polyphenol extract
The polyphenol extract obtained from EP defatted seeds
contained hydrolyzable and condensed tannins (Table 1).
Hydrolyzable tannins were determined as methyl gallate
formed during acid hydrolysis of tannins in methanol. These
tannins constituted 6.2 % of the dry extract and 10.14 % of the
total polyphenols determined with Folin-Ciocalteu method.
Condensed tannin content, determined with vanilin reagent,
was twice higher than the content of the hydrolyzable tannins.
They accounted for 12.5 % of the dry extract and 20.51 % of
the total polyphenols.
The UPLC-Q-TOF-MS analysis of EP pomace polyphenol
extract
The UPLC-Q-TOF-MS analysis of the extract showed the
presence of polyphenol compounds belonging to different
groups: flavan-3-ol derivatives (eight compounds, 25.48 mg/
g of extract), hydrolyzable tannin derivatives (seven com-
pounds, 38.31 mg/g), phenolic acids (three compounds,
32.45 mg/g), and flavonols (two compounds, 0.51 mg/g)—
Table 2. The analysis showed that the predominant com-
pounds in this extract were pentagalloyl glucose, ellagic acid,
catechin, and gallic acid, with a lot of accompanying poly-
phenols in lower concentrations.
EP pomace polyphenol extract has anti-inflammatory effect
in TNBS-induced colitis in mice
Macroscopic damage, colon wall thickness, and MPO activity
were assessed 3 days after TNBS treatment and were signif-
icantly increased compared with control animals, which re-
ceived vehicle alone (Fig. 1a–c). 5-ASA, which was used as a
reference drug, administered at the dose of 5 mg/kg i.c. (twice
daily) significantly attenuated colitis as shown by decreased
macroscopic score, reduced colon wall thickness, and MPO
activity (Fig. 1a–c). The i.c. administration of the EP pomace
polyphenol extract (5 mg/kg, twice daily) significantly re-
duced total macroscopic damage score and colon wall thick-
ness but did not affect the MPO activity in the TNBS-treated
mice (Fig. 1). Of note, mice treated with EP pomace polyphe-
nol extract regained their body weight faster than the vehicle-
treated animals. Oral administration of the EP pomace poly-
phenol extract (5 and 10 mg/kg, twice daily) significantly
reduced macroscopic damage score, MPO activity, and colon
wall thickness (Fig. 2a–c). Moreover, the anti-inflammatory
activity of the extract was dose-dependent. The EP pomace
polyphenol extract had no influence on naive animals when
administered either orally or i.c.
Microscopic evaluation of colon sections stained with
hematoxylin/eosin was in line with observation of the macro-
scopic parameters (Fig. 3). Histological analysis of sections of
distal colon from untreated animals showed intact epithelium,
absence of edema, and normal muscle architecture (Fig. 3a).
Severe microscopic damage, characterized by loss of mucosal
architecture, thickening of smooth muscle, presence of crypt
abscesses, and extensive cellular infiltrate, was observed in
Table 1 General characteristic of the evening primrose polyphenol
extract




Values are expressed as mean±SD, n≥3
aDetermined by Folin-Ciocalteu reagent as (+)-catechin equivalents
b Determined by vanillin reagent as (+)-catechin equivalents
c Determined by HPLC at 280 nm as methyl gallate
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colon specimens 3-day post-TNBS (Fig. 3b). The histological
changes were normalized after treatment with p.o. EP pomace
polyphenol extract (Fig. 3c).
EP pomace polyphenol extract does not affect the level
of IL-1β and TNF-α in mouse colon tissue
In order to examine whether the polyphenol extract from EP
pomace affects the expression of pro-inflammatory cytokines
in intestinal inflammation, we determined the levels of IL-1β
and TNF-α mRNA in mouse colon samples. Treatment with
TNBS induced a significant elevation of IL-1β mRNA in the
colon tissue (Fig. 3a). There was no statistical significance
between the level of IL-1β in TNBS-treated animals versus
TNBS+EP pomace polyphenol extract at the dose of 5 mg/kg
twice daily. However, a tendency toward this reduction may
be observed (Fig. 3a). Determination of TNF-α mRNA
showed no difference between any of the experimental groups
(Fig. 3b).
EP pomace polyphenol extract reduces the level of hydrogen
peroxide in mouse colon tissue
Since we showed that the EP pomace polyphenol extract
contains a considerable amount of phenolic antioxidants, the
hydrogen peroxide (H2O2) concentrations were determined in
the mouse colon samples as an indicator of the level of
oxidative stress (Fig. 4). We observed that the treatment of
mice with TNBS substantially raised the levels of H2O2
suggesting the induction of oxidative stress pathways in the
colon tissues (Fig. 3c). Oral administration of EP pomace
polyphenol extract for 3 consecutive days at the dose of
5 mg/kg (twice daily) significantly lowered the concentration
of H2O2 in the colon of TNBS-treated mice indicating a
substantial reduction in the oxygen free radicals (Fig. 3c).
Discussion
In this study, we characterized the chemical composition of
the EP pomace polyphenol extract, for which the source
material is a residue that remains after extraction of oil from
EP seeds. We also examined the anti-inflammatory activity of
the EP pomace polyphenol extract in a well-establishedmouse
model of TNBS-induced colitis. Moreover, we attempted to
investigate the potential mechanism of the anti-inflammatory
effect.
Using UPLC-Q-TOF-MS analysis, we found that the major
compounds present in the EP pomace polyphenol extract were
Table 2 The content (mg/g) and characterization of the phenolic compounds in the extract of EP pomace
Peak number tR (min) [M-H]
− (m/z) Compound Chemical entity Quantity (mg/g of dry extract)
1 1.03 169.0163 gallic acid phenolic acid 9.001
2 1.55 483.0756 digalloyl glucose hydrolyzable tannins 0.585
3 1.84 153.0204 protocatechuic acid phenolic acid 4.278
4 2.56 577.1349 procyanidin dimer flavan-3-ols 1.955
5 2.68 577.1349 procyanidin dimer flavan-3-ols 0.893
6 2.84 865.1905 procyanidin trimer flavan-3-ols 6.803
7 2.99 865.1906 procyanidin trimer flavan-3-ols
8 3.18 289.0723 catechin flavan-3-ols 12.255
9 4.14 729.1459 procyanidin dimer gallate flavan-3-ols 1.596
10 4.81 729.1459 procyanidin dimer gallate flavan-3-ols 0.484
11 5.01 787.0952 tetragalloyl glucose hydrolyzable tannins 0.304
12 5.32 441.0835 catechin gallate flavan-3-ols 1.493
13 5.51 787.0952 tetragalloyl glucose hydrolyzable tannins 1.347
14 6.25 787.0952 tetragalloyl glucose hydrolyzable tannins 2.639
15 6.44 787.0952 tetragalloyl glucose hydrolyzable tannins 3.919
16 6.53 787.0952 tetragalloyl glucose hydrolyzable tannins 1.571
17 6.63 300.9963 ellagic acid phenolic acid 19.169
18 7.28 477.0620 quercetin glucuronide flavonols 0.023
19 7.75 939.0977 pentagalloyl glucose hydrolyzable tannins 27.945
20 8.18 433.0735 quercetin pentoside flavonols 0.484
Flavan-3-ol derivatives were determined by HPLC at 280 nm as (+)-catechin, hydrolyzable tannin derivatives were determined at 280 nm as gallic acid,
and flavonol derivatives were determined at 360 nm as quercetin glucoside
s retention time
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pentagalloyl glucose, ellagic acid, catechin, and gallic acid,
with several accompanying polyphenols at lower concentra-
tions. Our results are in line with studies by Kiss et al. (2011);
Kiss and Naruszewicz 2012, who showed that pentagalloyl
glucose, catechin, and gallic acid were the main compounds in
the EP seed extracts. Studies on polyphenols present in the EP
extracts showed that these compounds are potent antioxidants;
they may also affect the innate immunity by interaction with
several pro-inflammatory pathways in the cell (Montserrat-de
la Paz et al. 2012; Wettasinghe et al. 2002).
Encouraged by this first evidence that the polyphenol ex-
tract from EP pomace contains high concentrations of poten-
tially beneficial anti-inflammatory compounds, we proceeded
by establishing its therapeutic activity in the mouse model of
colitis. We used a hapten-induced mouse model of intestinal
inflammation to evaluate the anti-inflammatory activity of EP
pomace polyphenol extract after oral and i.c. administration.
Further studies on the absorption of the EP pomace
polyphenol extract constituents are necessary to delineate
whether the effect is related to a local side of action only or
involves a systemic component as well.
Our data demonstrate that EP pomace polyphenol extract
alleviates experimental colitis in mice, and to the best of our
knowledge, this is the first report on the anti-inflammatory
action of the preparation. Based on our observations and
previous reports, showing the improvement of UC in humans
after treatment with EP seed oil, we may suggest that the
application of EP preparations, in particular the polyphenol
extract from EP pomace, may become a promising comple-
mentary therapy for patients suffering from IBD.
The anti-inflammatory and antioxidant properties of the EP
pomace polyphenol extract may arise from the phenolic con-
tent and high sum of phenolic groups in total. This includes
various phenolic acids, such as gallic and ellagic acid,
pentagalloyl glucose and flavanols, catechin and epicatechin
derivatives. This is in line with the study of Peschel et al.
Fig. 1 The EP pomace
polyphenol extract and 5-ASA
(both at the dose of 5 mg/kg,
twice daily over 3 days)
attenuated TNBS-induced colitis
in mice after i.c. administration.
Figure shows data for
macroscopic score (a), colon wall
thickness (b), MPO activity (c),
and changes in body weight (d).
&P<0.05, &&P<0.01,




represent mean±SEM of 6–8
mice per group
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(2007), who reported that the EP pomace extract has a potent
antioxidant activity, comparable to that of other commercially
available plant antioxidant materials, such as green tea or
grape seed. Moreover, Choiu et al. (2012) demonstrated that
Fig. 2 The EP pomace
polyphenol extract attenuates
colitis in a dose-dependent
manner after p.o. administration.
Figure shows data for
macroscopic scores (a), MPO
activity (b), colon wall thickness
(c), and changes in body weight
(d). &P<0.05, &&&P<0.001, as
compared to control mice.
*P<0.05, **P<0.01,
***P<0.001 versus TNBS-
treated animals. Data represent
mean±SEM of 6–8 mice per
group
Fig. 3 Microscopic total damage
score and representative
micrographs of hematoxylin and
eosin-stained sections of distal
colon from a control, b TNBS,
and c TNBS+EP (5 mg/kg, twice
daily, p.o.)-treated mice. Scale
bar=100 μm. &&&P<0.001, as
compared with control mice,
***P<0.001, as compared to
TNBS-treated mice. Data
represent mean±SEM of 6–8
mice per group
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the derivatives of catechin gallate, which we detected in the
EP preparation, potently suppress dextran sulfate sodium-
induced colitis and colon tumorigenesis in mice (Choiu et al.
2012). In contrast to Peschel et al. (2007), who only used
in vitro assays, we extended this observation to the in vivo
conditions and demonstrated for the first time that the EP
pomace polyphenol extract displays anti-inflammatory and
antioxidant action in the mouse GI tract.
The oxidative stress has been implicated in IBD pathogen-
esis. There are several antioxidative mechanisms in the GI
tract, which include enzymes, such as catalase and superoxide
dismutase, as well as nonenzymatic scavengers like glutathi-
one, flavonoids, and/or polyphenols. During intestinal inflam-
mation, concentration of H2O2 in the colonic tissue is in-
creased. In our study, the level of H2O2 was increased in
TNBS-treated animals when compared to the control group,
and the administration of EP pomace polyphenol extract re-
versed this change. Our data suggest that EP pomace poly-
phenol extract may have protective properties against free
oxygen radicals, possibly via the upregulation of cellular
antioxidant enzymes.
Surprisingly, we observed only a minor change in IL-1β
and no change in TNF-α levels upon treatment with EP
pomace polyphenol extract, what may suggest the lack of
influence of the preparation on the immune system. This
may result from low concentration of unsaturated fatty acids,
such as cis-linoleic acid, found in the preparation, which are
known to act directly on immune cells to reduce inflammation
(Bayles and Usatine 2009). Our preparation was nearly
completely defatted during the process of pomace production
and subsequent extractions. However, our observation needs
to be investigated further. It is well established that the level of
cytokines, such as TNF-α, is elevated during experimental
colitis (Ouyang et al. 2012; Xiong et al. 2013), while there
were no changes in TNF-α level observed in this study. We
may hypothesize that this was specific for our laboratory/
animal house conditions or strain of animals used in this
particular set of assays.
One of the potential targets for the EP pomace polyphenol
extract may be cyclooxygenase-2 (COX-2), which plays a
significant role in inflammation. Although the therapeutic
effectiveness of COX-2 inhibitors in experimental colitis is
controversial, some papers support their beneficial effects
when administered specifically to the colon (Lee et al.
2014). Docking studies showed that gallic acid binds in the
active site of COX-2 at the nonsteroidal anti-inflammatory
drug-binding site (Verma et al. 2013), where its carboxylate
moiety interacts with Arg120 and Glu524. On the other hand,
it is well known that various pro-inflammatory mediators are
upregulated in the colon epithelium of IBD patients. One of
the key players in the exacerbation of inflammation in the
colon is the nuclear transcription factor-kappaB (NF-κB),
whose activation upregulates expression of many genes in-
volved in immunity and inflammation (Verma et al. 2013). In
a noninflamed tissue, the activity of NF-κB is suppressed by a
specific inhibitor, IκB. It has been demonstrated that treatment
with gallic acid produced a dose-dependent increase in IκB
in vitro, thus inhibiting the activity of NF-κB and the pro-
inflammatory cascade (Ho et al. 2010). Well-established in-
hibitors of NF-κB, such as salicylates (e.g., 5-ASA) and
Fig. 4 The effect of the EP
pomace polyphenol extract
(5 mg/kg, twice daily over 3 days,
p.o.) on the a IL-1β mRNA, b
TNF-α mRNA, and c Oenothera
biennis H2O2 levels in colon
specimens isolated from TNBS-
treated mice. &P<0.05, as
compared to control mice.
*P<0.05 versus TNBS-treated
animals. Data represent mean±
SEM of 6–8 mice per group
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curcumin alleviated symptoms of IBD in both animal models
and humans (Suskind et al. 2013). This may also be the case
for the EP pomace polyphenol extract.
The results of our study encourage further investigations on
the polyphenol extract from the EP pomace and possible
translation of our findings into clinical conditions for the
benefit of patients with IBD. Therefore, safety, stability, and
additional in vivo activity tests for the polyphenol extract from
the EP pomace, especially in combination with other natural
antioxidants, are solicited.
Conclusion
EP pomace polyphenol extract, derived from the waste material
which remains after EP oil extraction, has a potent anti-
inflammatory action in the GI tract. Moreover, we showed that
both oral and i.c. administrations alleviate intestinal inflamma-
tion, thus making the EP pomace an attractive novel supple-
ment for future anti-inflammatory treatment in IBD patients.
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